Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Baruch Brenner

Showing results (31-40 of 120) with videos related to

Pageof 12
Sort By:
Journal of Surgical Oncology|September 2, 2011
Gastric cancer: biology and clinical manifestations in IsraelAyelet Dreznik, Ofer Purim, Efraim Idelevich, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|October 7, 2004
Is the delay in starting postoperative radiotherapy a key factor in the outcome of advanced (T3 and T4) laryngeal cancer?Gideon Marshak, Erica Rakowsky, Jacob Schachter, et al.
Critical Reviews in Oncology/Hematology|September 3, 2008
Gender and psychological distress among middle- and older-aged colorectal cancer patients and their spouses: an unexpected outcomeGil Goldzweig, Ayala Hubert, Natalio Walach, et al.
Journal of Medical Imaging and Radiation Sciences|February 19, 2020
What is the Best Way to Plan Rectum Three-Dimensional Conformal Radiotherapy in Prone Position-Classic Anatomical Landmark, Three Dimensional Fitting the Planning Target Volume, or Volumetric Modulated Arc?Yulia Kundel, Ran Ben Hur, Zipora Shochat, et al.
Onkologie|December 9, 2008
Overall survival with cisplatin and 5-fluorouracil neoadjuvant treatment in patients with esophageal cancer: single-center experienceEfraim Idelevich, Victor Buyevich, Svetlana Machlenkin, et al.
Anti-Cancer Drugs|January 14, 2012
The combination of docetaxel, cisplatin, and 5-fluorouracil in advanced gastric cancer: a single-institution experienceIrit Ben Aharon, Ofer Purim, Yulia Kundel, et al.
Cancer Reports (Hoboken, N.J.)|August 5, 2021
Proteomic analysis to identify markers for response to neoadjuvant treatment in esophageal and gastroesophageal cancerOran Zlotnik, Tal Goshen-Lago, Riad Haddad, et al.
The American Journal of Dermatopathology|December 25, 2004
c-kit expression in primary and metastatic merkel cell carcinomaMeora Feinmesser, Marisa Halpern, Ella Kaganovsky, et al.
Radiation Oncology (London, England)|October 24, 2014
Sphincter preservation in distal CT2N0 rectal cancer after preoperative chemoradiotherapyNir Wasserberg, Yulia Kundel, Ofer Purim, et al.
Diseases of the Colon and Rectum|December 24, 2010
Is local excision after complete pathological response to neoadjuvant chemoradiation for rectal cancer an acceptable treatment option?Yulia Kundel, Ronen Brenner, Ofer Purim, et al.
Pageof 12

Showing results (31-40 of 120) with videos related to

Sort By:
Pageof 12
Journal of Surgical Oncology|September 2, 2011
Gastric cancer: biology and clinical manifestations in IsraelAyelet Dreznik, Ofer Purim, Efraim Idelevich, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|October 7, 2004
Is the delay in starting postoperative radiotherapy a key factor in the outcome of advanced (T3 and T4) laryngeal cancer?Gideon Marshak, Erica Rakowsky, Jacob Schachter, et al.
Critical Reviews in Oncology/Hematology|September 3, 2008
Gender and psychological distress among middle- and older-aged colorectal cancer patients and their spouses: an unexpected outcomeGil Goldzweig, Ayala Hubert, Natalio Walach, et al.
Journal of Medical Imaging and Radiation Sciences|February 19, 2020
What is the Best Way to Plan Rectum Three-Dimensional Conformal Radiotherapy in Prone Position-Classic Anatomical Landmark, Three Dimensional Fitting the Planning Target Volume, or Volumetric Modulated Arc?Yulia Kundel, Ran Ben Hur, Zipora Shochat, et al.
Onkologie|December 9, 2008
Overall survival with cisplatin and 5-fluorouracil neoadjuvant treatment in patients with esophageal cancer: single-center experienceEfraim Idelevich, Victor Buyevich, Svetlana Machlenkin, et al.
Anti-Cancer Drugs|January 14, 2012
The combination of docetaxel, cisplatin, and 5-fluorouracil in advanced gastric cancer: a single-institution experienceIrit Ben Aharon, Ofer Purim, Yulia Kundel, et al.
Cancer Reports (Hoboken, N.J.)|August 5, 2021
Proteomic analysis to identify markers for response to neoadjuvant treatment in esophageal and gastroesophageal cancerOran Zlotnik, Tal Goshen-Lago, Riad Haddad, et al.
The American Journal of Dermatopathology|December 25, 2004
c-kit expression in primary and metastatic merkel cell carcinomaMeora Feinmesser, Marisa Halpern, Ella Kaganovsky, et al.
Radiation Oncology (London, England)|October 24, 2014
Sphincter preservation in distal CT2N0 rectal cancer after preoperative chemoradiotherapyNir Wasserberg, Yulia Kundel, Ofer Purim, et al.
Diseases of the Colon and Rectum|December 24, 2010
Is local excision after complete pathological response to neoadjuvant chemoradiation for rectal cancer an acceptable treatment option?Yulia Kundel, Ronen Brenner, Ofer Purim, et al.
Pageof 12